One of the most promising areas for growth in today’s economy is the life sciences sector. But with current conditions as they are, it is also one of the most challenging as sources of financing and the means for expansion become increasingly elusive.
Proskauer’s interdisciplinary Life Sciences Group brings together all the critical skill sets and experience to allow our firm to work with clients to build life sciences companies, protect inventions, obtain intellectual property rights, raise capital and negotiate and execute strategic deals.
Our Life Sciences Group represents early to later stage companies developing new medical technologies, universities and other academic or research institutions in realizing commercial value from the innovation of its faculty and research staff as well as mature pharma and biotech companies in filling their pipelines or spinning off technologies. We work with our clients to help them grow their businesses by helping them to gain access to financing, technology, partners and markets they need.
Our transactional lawyers provide day-to-day counseling and strategic advice regarding all facets of operating a business within the life sciences industry. We handle the most critical and highest stakes transactions for our life sciences clients and counsel them and their investors in strategic transactions, including collaborations, licensing agreements, development, marketing and promotion deals, and the sale of companies or their technology to major pharmaceutical and medical devices companies.
Our patent lawyers and technology specialists, many with Ph.D.s, have a broad range of technical expertise in fields that are key to the life sciences area, including biochemistry, biomedical engineering, biotechnology, chemistry, molecular biology, systems biology, medical devices, pharmaceuticals and drug discovery. These lawyers provide forward-looking intellectual property counseling in the area of patent and trademark procurement and portfolio development.
This interdisciplinary group is ranked among the best in the U.S. by Chambers USA and draws from many of our firm’s most well-regarded practices, including patent law, intellectual property, mergers and acquisitions, private equity, capital markets, health care, bankruptcy, finance and litigation, allowing us to seamlessly work with clients at each stage of their development and handle any challenges along the way. Whether raising capital, negotiating licensing agreements or terms of a sale or fighting back patent challenges, our team is equipped to help life sciences companies meet their business goals.
Areas of Focus
TransPharma Medical, Ltd., an Israeli medical device company, in an exclusive license agreement granting Eli Lilly worldwide licensing rights to TransPharma Medical’s ViaDerm-hPTH osteoporosis product and a non-exclusive license to its ViaDerm drug delivery system
Celgene Corporation, a multinational integrated biopharmaceutical company, in several deals, including its:
Public offering of 20 million shares of its common stock, generating gross proceeds of more than $1 billion
Agreement to acquire Pharmion Corporation, a global drug development company that focuses on hematological and solid tumor cancer drugs, for $2.9 billion
$425 million acquisition from Pfizer, Inc. of exclusive worldwide perpetual rights to VIDAZA®, an oncology drug